The first drug that slows Alzheimer's has finally received FDA approval | Engadget
Japanese drugmaker Eisai and US-based Biogen have received FDA approval for Leqembi, making it the first approved treatment available that can slow the progression of Alzheimer’s in patients..
Comment here to discuss with all recipients or tap a user's profile image to discuss privately.